| Calkins, Kortnee |
NCT04502407: Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer |
|
|
| Recruiting | 2 | 40 | US | Cisplatin-based Radiation Therapy, Cisplatin Chemotherapy | Cedars-Sinai Medical Center | HPV Positive Oropharyngeal Squamous Cell Carcinoma | 12/26 | 12/29 | | |
NCT04798781: Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma |
|
|
| Active, not recruiting | 2 | 16 | US | Telatinib, Keytruda, pembrolizumab | Andrew Hendifar, MD, EOC Pharma | Gastric Cancer, Hepatocellular Carcinoma | 02/24 | 02/25 | | |
NCT05341947: Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma |
|
|
| Not yet recruiting | 1 | 10 | US | Activated T cells | Jeremy Rudnick, M.D, Kairos Pharma | Recurrent Glioblastoma | 12/25 | 12/26 | | |
NCT04634539: Trial of First-line L-glutamine with Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer |
|
|
| Active, not recruiting | 1 | 18 | US | Gemcitabine, Nab-paclitaxel, L-glutamine, Endari | Jun Gong, MD, Emmaus Medical, Inc. | Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | 07/23 | 07/25 | | |
